Inhibition of the Expression of Inducible NO Synthase by Neuroactive Amino Acid Derivatives Phenibut and Glufimet In Vitro and Ex Vivo


Cite item

Full Text

Open Access Open Access
Restricted Access Access granted
Restricted Access Subscription Access

Abstract

The effects of glufimet and phenibut (glutamic acid and GABA derivatives, respectively) on concentration of inducible NO synthase and cGMP in LPS-activated mouse peritoneal macrophages and on NO end products in their culture medium were examined in vitro and ex vivo. Addition of LPS into culture medium elevated concentration of NO metabolites in this medium and increased concentration of inducible NO synthase and cGMP in the lysates of peritoneal macrophages, whereas incubation of the cells with examined agents applied at concentration of 10—5 M diminished these indices. Similar results were obtained with intraperitoneal injection of LPS, glufimet, and phenibut. In culture medium containing peritoneal macrophages from the mice injected with LPS (100 μg/kg), the concentrations of inducible NO synthase and cGMP as well as the total concentration of nitrite and nitrate ions increased, whereas in culture medium with the cells from LPS-exposed mice treated with glufimet (28.7 mg/kg) and phenibut (50 mg/kg) these indices significantly decreased.

About the authors

A. V. Borisov

Department of Pharmacology and Biopharmacia, Faculty of Continuing Medical Education, Volgograd State Medical University, Ministry of Health of the Russian Federation

Email: igor.prokofiev@mail.ru
Russian Federation, Moscow

I. I. Prokofiev

Department of Pharmacology and Biopharmacia, Faculty of Continuing Medical Education, Volgograd State Medical University, Ministry of Health of the Russian Federation

Author for correspondence.
Email: igor.prokofiev@mail.ru
Russian Federation, Moscow

I. S. Mokrousov

Department of Pharmacology and Biopharmacia, Faculty of Continuing Medical Education, Volgograd State Medical University, Ministry of Health of the Russian Federation

Email: igor.prokofiev@mail.ru
Russian Federation, Moscow

V. N. Perfilova

Department of Pharmacology and Biopharmacia, Faculty of Continuing Medical Education, Volgograd State Medical University, Ministry of Health of the Russian Federation

Email: igor.prokofiev@mail.ru
Russian Federation, Moscow

I. N. Tyurenkov

Department of Pharmacology and Biopharmacia, Faculty of Continuing Medical Education, Volgograd State Medical University, Ministry of Health of the Russian Federation

Email: igor.prokofiev@mail.ru
Russian Federation, Moscow


Copyright (c) 2017 Springer Science+Business Media, LLC, part of Springer Nature

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies